Literature DB >> 17201097

Chlamydophila pneumoniae in horses: a seroepidemiological survey in Italy.

Antonietta Di Francesco1, Manuela Donati, Loretta Mattioli, Marzia Naldi, Daniela Salvatore, Giovanni Poglayen, Roberto Cevenini, Raffaella Baldelli.   

Abstract

We tested 731 sera from apparently healthy light horses against Chlamydophila pneumoniae, by a microimmuno-fluorescence (MIF) test. To verify cross-reactions with other species of chlamvdiae, all sera with an antibody titre > or = 32 to C. pneumoniae were tested against both C. psittaci and C. abortus. Antibodies to C. pneumoniae were detected in 194 out of 731 (26.5%) samples tested, with antibody titres ranging from 32 to 1024. No antibody titre > or = 32 was detected in sera to C. abortus. Only few sera with a high antibody titre to C. pneumoniae reacted weakly with C. psittaci at the dilution of 1:32.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17201097

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  3 in total

Review 1.  Evolution to a chronic disease niche correlates with increased sensitivity to tryptophan availability for the obligate intracellular bacterium Chlamydia pneumoniae.

Authors:  Wilhelmina M Huston; Christopher J Barker; Anu Chacko; Peter Timms
Journal:  J Bacteriol       Date:  2014-03-28       Impact factor: 3.490

2.  Chlamydophila spp. infection in horses with recurrent airway obstruction: similarities to human chronic obstructive disease.

Authors:  Dirk Theegarten; Konrad Sachse; Britta Mentrup; Kerstin Fey; Helmut Hotzel; Olaf Anhenn
Journal:  Respir Res       Date:  2008-01-29

3.  An epizootic of Chlamydia psittaci equine reproductive loss associated with suspected spillover from native Australian parrots.

Authors:  Cheryl Jenkins; Martina Jelocnik; Melinda L Micallef; Francesca Galea; Alyce Taylor-Brown; Daniel R Bogema; Michael Liu; Brendon O'Rourke; Catherine Chicken; Joan Carrick; Adam Polkinghorne
Journal:  Emerg Microbes Infect       Date:  2018-05-16       Impact factor: 7.163

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.